Pharmaceutical

Filter

Current filters:

None

Popular Filters

73 to 97 of 7220 results

Polyphor appoints Michael Altorfer as chief executive

Polyphor appoints Michael Altorfer as chief executive

17-03-2015

Privately-held Swiss pharma company Polyphor has appointed Michael Altorfer as its new chief executive.

BoardroomMichael AltorferPharmaceuticalPolyphorSwitzerland

Positive final Phase IIa safety results for Neurotrope’s Alzheimer's drug

Positive final Phase IIa safety results for Neurotrope’s Alzheimer's drug

17-03-2015

US orphan disease specialist Neurotrope saw its shares rise over 5% to $1.25 after it released secondary…

bryostatin-1NeurologicalNeurotropePharmaceuticalResearch

Russian government may allow parallel drug imports to the country

Russian government may allow parallel drug imports to the country

17-03-2015

The Russian government may allow parallel imports (imports of non-counterfeit product from another country…

Markets & MarketingPharmaceuticalPoliticsRussia

Lilly, GSK and Janssen join UK government's $100 million Dementia Discovery Fund

Lilly, GSK and Janssen join UK government's $100 million Dementia Discovery Fund

17-03-2015

The UK’s Health Secretary Jeremy Hunt has announced a collaborative dementia research initiative between…

Eli LillyGSKJanssenNeurologicalPharmaceuticalResearchUK

Actavis’ acquisition of Allergan cleared by Europe

Actavis’ acquisition of Allergan cleared by Europe

17-03-2015

Ireland-headquartered generics major Actavis has received clearance from the European Commission for…

ActavisAllerganEuropeMergers & AcquisitionsPharmaceutical

Sanofi Pasteur partner Shantha delivers 400,000 doses of pentavalent vaccine in India

Sanofi Pasteur partner Shantha delivers 400,000 doses of pentavalent vaccine in India

17-03-2015

Shantha Biotechnics, the India-based affiliate of Sanofi Pasteur, the vaccines division of Sanofi, has…

IndiaMarkets & MarketingPharmaceuticalProductionSanofi PasteurShan5ShanthaVaccines

Cyprus in danger of medicinal products being withdrawn

Cyprus in danger of medicinal products being withdrawn

17-03-2015

The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) is concerned about…

EuropePharmaceuticalPoliticsPricing

AstraZeneca’s Brilinta reduced thrombotic CV events in patients with history of heart attack

16-03-2015

Anglo-Swedish pharma major AstraZeneca released much anticipated trial results for its blood-thinning…

AstraZenecaBrilintaCardio-vascularFinancialPharmaceuticalResearch

Fear mongering jeopardizing “21st Century” trade deal, says Medicines Australia

16-03-2015

The Trans Pacific Partnership Agreement (TPP) will open up vast new markets for Australian companies,…

AustraliaPatentsPharmaceuticalPolitics

Actavis' sNDA for Saphris approved by FDA

Actavis' sNDA for Saphris approved by FDA

16-03-2015

The US Food and Drug Administration has approved the supplemental New Drug Application for Saphris (asenapine),…

ActavisNeurologicalPharmaceuticalRegulationSaphrisUSA

Amgen and Sanofi/Regeneron's PCSK9 inhibitors halve risk of cardiovascular events

Amgen and Sanofi/Regeneron's PCSK9 inhibitors halve risk of cardiovascular events

16-03-2015

Results of a new study published in the New England Journal of Medicine have shown that the experimental…

AmgenCardio-vascularPharmaceuticalPraluentRegeneronResearchSanofi

Baxter reports positive results from BAX 817 Phase III trial

Baxter reports positive results from BAX 817 Phase III trial

16-03-2015

American health care company Baxter International (Nasdaq: BAX) has reported positive results from its…

BaxterBaxter InternationalHematologyPharmaceuticalResearch

Kura Oncology gains rights to Janssen’s tipifarnib

14-03-2015

USA-based clinical-stage drug developer Kura Oncology has entered into an agreement with Janssen Pharmaceutica,…

FinancialJanssen PharmaceuticaJohnson & JohnsonKura OncologyLicensingMergers & AcquisitionsOncologyPharmaceuticaltipifarnib

FDA again delays decision on Merck’s investigational drug sugammadex

14-03-2015

The US Food and Drug Administration has cancelled the meeting of the Anesthetic and Analgesic Drug Products…

Merck & CoNeurologicalPharmaceuticalRegulationsugammadexUSA

Pfizer’s Lyrica fails in adolescents with fibromyalgia

13-03-2015

US pharma giant Pfizer today released disappointing top-line results of a double-blind Phase IV study…

LyricaNeurologicalPfizerPharmaceuticalResearch

Highlights of EMA’s PRAC March meetings

13-03-2015

The European Medicines Agency has released highlights of the March 9-12 meeting of its Pharmacovigilance…

Anti-Arthritics/RheumaticscodeineEuropeNeurologicalNovartisPharmaceuticalRegulationzoledronic acid

Pharma must look to other industries for models of managing high cost of new drugs

Pharma must look to other industries for models of managing high cost of new drugs

13-03-2015

New financing approaches are required in order to account for the emerging extremely expensive drugs…

GileadPharmaceuticalPricingRAND CorporationSovaldi

GSK plans to sell half its stake in Aspen Pharmacare

GSK plans to sell half its stake in Aspen Pharmacare

13-03-2015

UK pharma major GlaxoSmithKline says that it plans to dispose of half its current 12.4% stake in South…

Aspen HoldingsBusiness FinanceFinancialGSKPharmaceutical

Most clinical trial results not reported within ClinicalTrials.gov guidelines

Most clinical trial results not reported within ClinicalTrials.gov guidelines

13-03-2015

Although pharma companies are required to report clinical trial results to ClinicalTrials.gov in a timely…

MedicineNew England JournalPharmaceuticalResearchUSA

Is big pharma ignoring an impending antibiotic-resistance crisis?

Is big pharma ignoring an impending antibiotic-resistance crisis?

12-03-2015

Despite big Pharma being criticized for not doing enough to tackle an impending antibiotic-resistance…

Antibiotics and Infectious diseasesGlobalPatentsPharmaceuticalResearch

EC backs expanded approval of Novo Nordisk’s Tresiba for children

EC backs expanded approval of Novo Nordisk’s Tresiba for children

12-03-2015

Danish diabetes care giant Novo Nordisk says that the European Commission has approved the expanded use…

DiabetesEuropeNovo NordiskPharmaceuticalRegulationTresiba

Takeda transfers license agreement on HPV vaccine to Kaketsuken

Takeda transfers license agreement on HPV vaccine to Kaketsuken

12-03-2015

Japan’s largest drugmaker Takeda has transferred its license agreement with the Japan Health Sciences…

Anti-viralsJapanLicensingOncologyPharmaceuticalResearchTakeda Pharmaceuticals

HUYA makes new appointments to executive team

HUYA makes new appointments to executive team

12-03-2015

HUYA Bioscience International has appointed Alain Rolland as executive vice president and chief scientific…

Amarna PeriodBoardroomHUYA BioscienceHuya Bioscience InternationalPharmaceutical

73 to 97 of 7220 results

Back to top